Authors: Raza, A Qawi, H Lisak, L Andric, T Dar, S Andrews, C Venugopal, P Gezer, S Gregory, S Loew, J Robin, E Rifkin, S Hsu, WT Huang, RW

Citation: A. Raza et al., Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone, BLOOD, 95(5), 2000, pp. 1580-1587

Authors: Ali, A Mundle, SD Ragasa, D Reza, S Shetty, V Mativi, BY Cartlidge, JD Azharuddin, M Qawi, H Dar, S Raza, A

Citation: A. Ali et al., Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes, J HEMATH ST, 8(4), 1999, pp. 343-356

Authors: Reza, S Dar, S Andric, T Qawi, H Mundle, S Shetty, V Venugopal, P Ali, I Lisak, L Raza, A

Citation: S. Reza et al., Biologic characteristics of 164 patients with myelodysplastic syndromes, LEUK LYMPH, 33(3-4), 1999, pp. 281-287

Authors: Dar, S Mundle, S Andric, T Qawi, H Shetty, V Reza, S Mativi, BY Allampallam, K Ali, A Venugopal, P Gezer, S Broady-Robinson, L Cartlidge, J Showel, M Hussaini, S Ragasa, D Ali, I Chaudhry, A Waggoner, S Lisak, L Huang, RW Raza, A

Citation: S. Dar et al., Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis, EUR J HAEMA, 62(2), 1999, pp. 90-94

Authors: Goyal, R Qawi, H Ali, I Dar, S Mundle, S Shetty, V Mativi, Y Allampallam, K Lisak, L Loew, J Venugopal, P Gezer, S Robin, E Rifkin, S Raza, A

Citation: R. Goyal et al., Biologic characteristics of patients with hypocellular myelodysplastic syndromes, LEUK RES, 23(4), 1999, pp. 357-364